ArticleFrontiers in oncology2026

Bcl-2 inhibitor resistance in diffuse large b-cell lymphoma: establishing a prognostic signature and targeting alpha protein kinase 1.

Jingjing Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.